TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Grade 3 or 4 hematological toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: BMQ-S necessity scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: median pain scores 30 min after the femoral block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: morphine equivalents required during the 30 min post‐femoral block
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Total QoR-40 score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Total consumption of remifentanil
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: verbal comprehension score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: motor skills scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of mandibular osteoradionecrosis (ORN)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom from associated symptoms (photophobia, phonophobia, nausea)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achieving normal function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Overall quality of life scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Taste preference rate for strawberry preparation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Emotional valence for strawberry preparation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: survival prediction
Endpoint domain: Mortality/survival
Primary endpoint: Urinary tract infection (UTI) rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Quality of life gains
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Forced vital capacity improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: VAS pain score reduction during activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS pain score reduction at night
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Optimal cut-off score of 2 points
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: health problem prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Internal Leakage Pressure (ILP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Median time from diagnosis to first PC consult
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PC consultation rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of patients with no subsequent PC encounter after discharge
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean decrease in body weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical cure rate on Day 15
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Emergency room visits within the first 6 months after discharge
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: global methylation patterns in nasal cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Improvement in lubrication scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Improvement in dyspareunia scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Improvement in satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement in orgasm
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: total OABS sub score (OABSS-ss)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical component summary
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Reduction in periodontal microbial load
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in TNF-α levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maternal reports of substance use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Household expenditures on alcohol or cigarettes
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Accuracy of infection identification criteria
Endpoint domain: Adverse events/effects
Primary endpoint: event-rate
Endpoint domain: Mortality/survival
Primary endpoint: Self-rating anxiety scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of recovery 40 total score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Receipt of all seven services
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Receipt of all 13 topics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: norepinephrine requirements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum malonaldehyde levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Odds of overweight and obesity associated with total BCAA level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Respiratory failure
Endpoint domain: Adverse events/effects
Primary endpoint: ADHD‐RS‐IV total score effect size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of significant treatment-emergent adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Attention bias to threat-related stimuli
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Negative interpretation bias
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Implicit cravings for low-calorie sweets
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Activation levels of the left dorsolateral prefrontal cortex
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Activation levels of the left orbitofrontal area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: back extensor muscle endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Proportion of healed DU subjects
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of PORC
Endpoint domain: Adverse events/effects
Primary endpoint: Study participation rate
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Knowledge about the study
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: SARS-CoV-2 neutralizing antibody titres
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Seroconversion rates of neutralizing antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Requirement and amount of blood transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Need for a ventilator
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Restoration loss after 18 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: adherence time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean sagittal DAr
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PSS (aesthetic satisfaction)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: total operation and ischemia time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Clinical impact of AI intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expiratory volume (VE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Forced expiratory volume in 0.3 s (FEV0.3)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Proportion of patients achieving improved standards of preventive care
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Increased prescription of statins
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean days on Dabigatan/week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients taking dabigatran twice/day as prescribed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients fully adherent at 90 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cardiovascular death rate
Endpoint domain: Mortality/survival
Primary endpoint: disabling stroke rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: CL-preventive behaviors in adolescents
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: EQ5D index score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: EQ-visual analogue scale (VAS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: surgency/extraversion
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Quadriceps muscle strength improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hamstrings muscle strength improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pelvic Floor Distress Inventory‐20 total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Net benefit of clinical trials
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rates of intraoperative hemostatic interventions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Postoperative interventions for bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: percentage of participants reporting no pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: analgesic usage
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reduction in biomarkers related to fibrosis, inflammation, and thrombosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: VAS scale at rest and movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WOMAC index for pain, stiffness, and functional insufficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Leken index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CTVHR D90%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bladder D2cm3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: V85Gy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cold pressor pain threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: heat pain threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gingival gap size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: compliance in children with amblyopia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative sensitivity (POS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacist self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Index level FA grade development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bowel bother scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: SF-12 physical component scores (PCS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Patient-reported discomfort
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SLR score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of S. haematobium infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: 30-day hospitalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: 180-day hospitalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: 1-year hospitalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: post recovery lactate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: longer ventilator requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retrospective memory problems
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: obesity risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: proportion of patients requiring transfusions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Increase in BDNF levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urine Output (UOP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Resting I‐FABP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Urine lactulose‐to‐rhamnose ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Upper GI symptoms
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Mean vaginal depth after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sexual satisfaction of patients
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Complete renal remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: myopia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: axial length
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Relief from xerostomia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unstimulated saliva flow rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of AP on MRI sequences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: whole mouth plaque score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3D step height (μm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total ASQi scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hypoglycemia risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Glycemic excursions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Knowledge of essential nutrition principles
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to recognize physiological derangements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fewer physiological derangements overlooked
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary stent patency duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upper airway volume increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Most constricted area increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Serum level of IL-10 at 24 hours after ICU admission
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Amounts of IL-8 at post-CPB time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Time to Treatment Change (TTCx)
Endpoint domain: Mortality/survival
Primary endpoint: Knowledge of menstruation-related topics
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: translational displacement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PPC rate
Endpoint domain: Adverse events/effects
Primary endpoint: AL incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Mean hospital LOS
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: maximum knee extensor strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: eccentric torque
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: vastus lateralis fascicle length
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: vastus medialis fascicle length
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: FMA-LE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: FMA-total
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Modified Rankin Scale score (0-2) at 6 months follow-up
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: National Institutes of Health Stroke Scale (median 3.5) at 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mortality due to complications
Endpoint domain: Mortality/survival
Primary endpoint: overall social adjustment change
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: interpersonal anguish change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: self-care change
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: sexual relations change
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Plasma Cmax of MGS0008
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration–time curve (AUC) of MGS0008
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 17OHP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: A4 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: nocturnal BP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: connective tissue protein synthesis rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: moisture and elasticity increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: pore size reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: wrinkle depth decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: gait adaptation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite outcome of kidney function decline, kidney failure, or death due to kidney disease
Endpoint domain: Mortality/survival
Primary endpoint: mean frailty score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of change in mean frailty score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incident frailty
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fractional excretion of nitrate (FEnitrate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Perceived risk of IQOS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mean percentage of new bone formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraoperative need for RBC transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Total intravenous fluid intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction rate with VGR
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Increase in GDMT class prescription
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HIV retesting rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: esthetic result
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 25‐OHD levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in SSB consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in self-reported SSB habits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes